Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LUBIPROSTONE Cause Wrong technique in product usage process? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Wrong technique in product usage process have been filed in association with LUBIPROSTONE (Amitza). This represents 0.8% of all adverse event reports for LUBIPROSTONE.

10
Reports of Wrong technique in product usage process with LUBIPROSTONE
0.8%
of all LUBIPROSTONE reports
4
Deaths
5
Hospitalizations

How Dangerous Is Wrong technique in product usage process From LUBIPROSTONE?

Of the 10 reports, 4 (40.0%) resulted in death, 5 (50.0%) required hospitalization.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LUBIPROSTONE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does LUBIPROSTONE Cause?

Diarrhoea (170) Drug ineffective (131) Nausea (110) Constipation (82) Vomiting (75) Dizziness (59) Abdominal distension (57) Dyspnoea (53) Headache (47) Abdominal pain (45)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which LUBIPROSTONE Alternatives Have Lower Wrong technique in product usage process Risk?

LUBIPROSTONE vs LUCENTIS LUBIPROSTONE vs LUCRIN DEPOT LUBIPROSTONE vs LUMASIRAN LUBIPROSTONE vs LUMATEPERONE LUBIPROSTONE vs LUMIGAN

Related Pages

LUBIPROSTONE Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process LUBIPROSTONE Demographics